Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (Clinical Trials Optional)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The High Impact Specialized Innovation Programs (SIPs) aim to facilitate the development and demonstration of distinctive hub capabilities, research platforms, and resources designed to address urgent challenges and barriers in clinical and translational science at designated Clinical and Translational Science Awards (CTSA) Program Hubs. These programs are intended to establish a solid foundation for future broader adoption and dissemination of innovative capabilities across additional CTSA Program Hubs. Funding is provided under the authority of the Public Health Service Act and relevant federal regulations, with allocation contingent upon a rigorous peer-review process in line with NIH standards. This opportunity is a limited competition forecast inviting eligible organizations to apply for support. Applications must meet specified eligibility criteria and will undergo merit-based evaluation to determine funding. The program supports projects that may or may not involve clinical trials and is managed by the National Institutes of Health within the Department of Health and Human Services. Interested applicants can seek additional information and guidance from the designated CTSA Program Branch, Division of Clinical Innovation.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded Clinical and Translational Science Awards (CTSA) Program Hubs. Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
